[ad_1]
According to her, the decision on the registration of the vaccine will be made at the end of December. The vaccine is nearly 95% effective and has virtually no side effects in the 30,000 people who have been tested.
The EMA is scheduled to meet on December 29 with representatives of the 27 EU drug agencies. A decision to register the first coronavirus vaccine in the EU will then be announced, the director said. Until then, the experts will evaluate the results of the investigation day and night. The director stressed that there will be “no compromises” in evaluating the safety of the vaccine.
The EMA is also evaluating the vaccine from the pharmaceutical company Moderna. A decision on his registration is expected on January 12.
In the UK, the Biontech and Pfizer vaccines are already urgently registered and in use. However, according to Mr. Cooke, this registration is only valid for a limited time. Meanwhile, the EMA is seeking full approval of the vaccine.
The head of the EMA also commented positively on the possible side effects of the vaccine. “There are no side effects worth mentioning, much less serious,” he said. The vaccine is effective in both old and young people.
No part of this publication may be reproduced without the written permission of ELTA.
[ad_2]
